Literature DB >> 31719804

Detailed analysis of dose difference in using water as tissue-equivalent material in 252Cf brachytherapy.

Izadi Vasafi Gholamhossein1, Mehdi Firoozabadi Mohammad1, Ghorbani Mahdi2.   

Abstract

AIM: The purpose of this study is to analyse how small variations in the elemental composition of soft tissue lead to differences in dose distributions from a 252Cf brachytherapy source and to determine the error percentage in using water as a tissue-equivalent material.
BACKGROUND: Water is normally used as a tissue-equivalent phantom material in radiotherapy dosimetry.
MATERIALS AND METHODS: Neutron energy spectra, neutron and gamma-ray dose rate distributions were calculated for a 252Cf AT source located at the center of a spherical phantom filled with various types of tissue compositions: adipose, brain, muscle, International Commission on Radiation Units and Measurements (ICRU) report No. 44 9-component soft tissue and water, using Monte Carlo simulation.
RESULTS: The obtained results showed differences between total dose rates in various tissues relative to water varying between zero and 4.94%. The contributions of neutron and total gamma ray doses to these differences are, on average, 81% and 19%, respectively. It was found that the dose differences between various soft tissues and water depend not only on the soft tissue composition, but also on the beam type emitted from the 252Cf source and the distance from the source.
CONCLUSION: Assuming water as a tissue-equivalent material, although leads to overestimation of dose rate (except in the case of adipose tissue), is acceptable and suitable for use in 252Cf brachytherapy treatment planning systems based on the recommendation by the ICRU that the uncertainties in dose delivery in radiotherapy should be lower than 5%.
© 2019 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  252Cf; Brachytherapy; Dose distribution; Tissue composition

Year:  2019        PMID: 31719804      PMCID: PMC6838967          DOI: 10.1016/j.rpor.2019.10.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  12 in total

1.  Neutron dosimetry for a general 252Cf brachytherapy source.

Authors:  M J Rivard
Journal:  Med Phys       Date:  2000-12       Impact factor: 4.071

2.  Measurement quality assurance for ionizing radiation dosimetry.

Authors: 
Journal:  J ICRU       Date:  2006-12

3.  Detailed dose distribution prediction of Cf-252 brachytherapy source with boron loading dose enhancement.

Authors:  J Ghassoun; D Mostacci; V Molinari; A Jehouani
Journal:  Appl Radiat Isot       Date:  2009-10-14       Impact factor: 1.513

4.  Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol.

Authors:  M J Rivard; J G Wierzbicki; F Van den Heuvel; R C Martin; R R McMahon
Journal:  Med Phys       Date:  1999-01       Impact factor: 4.071

5.  What degree of accuracy is required and can be achieved in photon and neutron therapy?

Authors:  B J Mijnheer; J J Battermann; A Wambersie
Journal:  Radiother Oncol       Date:  1987-03       Impact factor: 6.280

6.  Tissue composition effect on dose distribution in neutron brachytherapy/neutron capture therapy.

Authors:  Mohsen Khosroabadi; Bagher Farhood; Mahdi Ghorbani; Nima Hamzian; Homa Rezaei Moghaddam; David Davenport
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-10

7.  Dose distributions around a californium-252 needle.

Authors:  R D Colvett; H H Rossi; V Krishnaswamy
Journal:  Phys Med Biol       Date:  1972-05       Impact factor: 3.609

8.  Calculated depth dose tablets for californium-252 sources in tissue.

Authors:  V Krishnaswamy
Journal:  Phys Med Biol       Date:  1972-01       Impact factor: 3.609

9.  Californium isotopes proposed for intracavity and interstitial radiation therapy with neutrons.

Authors:  C S Schlea; D H Stoddard
Journal:  Nature       Date:  1965-06-05       Impact factor: 49.962

10.  Measurement of augmentation of 252Cf implant by 10B and 157Gd neutron capture.

Authors:  J G Wierzbicki; Y Maruyama; A T Porter
Journal:  Med Phys       Date:  1994-06       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.